Business SK bioscience and KDCA initiate development of Avian influenza vaccine
By Diplomacy Journal Lee Kap-soo SK bioscience has been selected for the Korea Disease Control and Prevention Agency (KDCA)’s Priority Infectious Disease Pandemic Preparedness Rapid R&D Support Program, the company said on May 6. This government-led initiative aims to develop vaccines against avian influenza – identified as a high-risk candidate for the next pandemic. SK bioscience was chosen for its proven technological capabilities as the only domestic company to have commercialized cell-culture-based vaccines for both influenza and COVID-19. Under the program, SK bioscience and KDCA wil